Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
InWith Corporation @ InWithCorp
$InWith News: A new US Patent was filed yesterday for more breakthrough technologies to enable display of information to the eyes, from the contact lens medium. The new patent pending has a priority date established early in 2017 and will become public by USPTO in due course.
InWith has confirmed a previous tweet that the A/S will be lowered to 10 Million near conversion date. Currently the Secretary of State in Delaware filing shows 100 Million A/S in its initial filing on 1/4/2017 over 14 months ago. Since that time new developments have happened for the better as WSGR has taken an equity position in EPGL and apparently the leading firm in Silicon Valley believes 10 Million A/S is the number they want as they are now involved, should see a new filing in coming weeks with SOS to confirm this reduction of A/S. Cant wait for $EPGL to be converted to InWith Corp. Might take 2 years to IPO to NASDAQ, but a buyout can also happen at any time after conversion.
@InWithCorp $EPGL to end trading soon, in next 14-21 days. New $InWith shares to be distributed to all $EPGL holders beginning March 12th and completed by March 30th. New $InWith website and buy/sell matchmaker up March 15th.
info@inwithcorp.com is the email address for all $EPGL shareholders to use from today forward. @InWithCorp is the Twitter address for all news and updates from today forward.
Will anyone here be attending the Special Meeting being held today in CA?
and just as illusory...
$EPGL/InWith is a joke.
That's equivalent to .10 per share of the 5B A/S EPGL.
$InWith Corp. sets initial share price at $50.00 per share in private offering effective upon conversion of the $EPGL shareholders to $InWith Corp. The authorized shares of $InWith Corp. shall be set at 10 million.
https://twitter.com/InwithCorp
Great Tweet $EPGL ALERT: $InWith Corp. makes bid to takeover $EPGL in February 2018. $EPGL shareholders of record by January 10, 2018 can participate in the Proxy Vote for approval. The bid, if accepted, will see all $EPGL Shareholders receiving a large INCREASE in their equity percent and gifted shares of $InWith Corp. will be added to the takeover shares offered. $InWith now has established a full mgt. team and has top Silicon Valley law firm Wilson Sonsini (wsgr) as counsel. WSGR represents a "who's who" of tech giants including Google. $InWith Corp. Mgt will position the company for a future NASDAQ or NYSE IPO. Authorized private InWith Corp. shares will only be 10 million to start, but the $InWith per share price is anticipated to be many fold that of present $EPGL. $InWith Corp. Mgt. plans to position the new life sciences and technology company as a hot start-up in a very hot field using $EPGL developed IP and talent as well as added talent and IP. $InWith will team with major NYSE and NASDAQ corporations whom have already expressed interest in the new company. Many details of the equity increase for $EPGL Shareholders and the coming Proxy Vote will be released before January 10, 2018. Happy New Year!
I received a reply back from an email I sent this morning to EPGL IR below is my email and their reply....
Hello:
I see that on Dec 12, 2017 Google (Verily Scienses) was issued a Patent # 9,841,614 for a Flexible Conductor for use within a Contact Lens? I assume one of the differences is that this IP is layered? My question is... Is a Conductor the same as a Circuit? How does this IP compare to EPGL's Flexible Circuit?
In a Tweet on Dec 11th it was said that " $InWith Corp. is Now in Final Negotiation with Top Venture Capitals." and then nothing is said in the update about InWith. I think most of us were expexting to hear some details concerning the Capital Raise. Is Inwith having trouble raising the funds to do the BuyOut? Is InWith still going to make a buyout offer for EPGL? And is InWith's per share offer anywhere near the true value that Mr Hayes is expecting?
Have there been other offers made for EPGL other then that from InWith? IMO the tweets suggest there have been other offers. If not please stop teasing and misleading us shareholders on. Very frustrating.
As for EPGL's Tweet on Sep 21st saying that "EPGL shareholders may be cheerful going into Fall & New Year." So far IMO where EPGL's share price is concerned EPGL's shareholders have no reason to be Jolly.
Sincerely, Judy
.................................................
EPGL IR reply
No InWith has great interest. Just being careful who it decides to go with as interest has picked up quite a bit.
Regarding VERILY, if it isn't for mass manufacturing molded for stretchable circuitry, it isn't what EPGL has. Layering is not the holy grail.
And sometimes I wonder if it is not a trick of Epgl. Maybe it is JNJ, they went beyond the first rights agreements but they dont want to say it now.
Do the sentence of the PR is a clue with an inverted logic to disrupt our brains lol???
"This goes beyond a right of first negotiation to now having EPGL technology at the center of a commercial project that addresses a multi-billion-dollar market in the field."
https://finance.yahoo.com/news/epgl-contact-lens-technology-chosen-173130197.html?.tsrc=applewf
well just for the fun I would add Valeant company ( Nyse = VRX) to this list of 3. Everything is possible. Place the bets. lol.
ExxonMobil
Tesla
Netflix
Here are my 3 guesses as to which NYSE company is working with EPGL to build it's new electronic contact lens sensor prototype.
ABT
IBM
RTN
Anyone else care to speculate?
$EPGL Readies for Building a New Electronic Contact Lens Sensor Prototype with a Major NYSE, Multi-Billion Co. $InWith Corp. is Now in Final Negotiation with Top Venture Capitals. Another Update Here by Dec 20th. #Leading #IP" 11 December
it seems they are closer now, very close
judypudy, maybe because the phony InWith is old news never to be revisited like so many other previous announcements by EPGL.
Good luck.
How's come the FB page no longer lets me in? Franck said it was because I had no picture, but I had a picture on file. What gives?
3 more weeks until update of EPGL's capital raise. Where it's smart contact lens patents land?
EP Global Comm. Inc.? @EPGLMed 35 minutes ago
$EPGL $InWith meeting in San Francisco last week. Exciting time. Watch for developments coming. #LeadingGiants
https://twitter.com/EPGLMed?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5Eauthor
Wilson Sonsini Goodrich & Rosati is going to great things for EPGL. Why? Because they know they are legit, with groundbreaking technology that will shape the future of the smart contact lens market.
WILSON SONSINI GOODRICH & ROSATI
Wilson Sonsini Goodrich & Rosati is the premier legal advisor to technology, life sciences, and other growth enterprises worldwide. We represent companies at every stage of development, from entrepreneurial start-ups to multibillion-dollar global corporations, as well as the venture firms, private equity firms, and investment banks that finance and advise them. The firm's broad range of services and practice areas are focused on addressing the principal challenges faced by the management, boards of directors, shareholders, and in-house counsel of our clients.
The firm is nationally recognized for providing high-quality services to address the legal solutions required by its enterprise and financial institution clients. Our services include corporate law and governance, public and private offerings of equity and debt securities, mergers and acquisitions, securities class action litigation, intellectual property litigation, antitrust counseling and litigation, joint ventures and strategic alliances, technology licensing and other intellectual property transactions, tax, and employee benefits and employment law, among other areas. Our distinguished international roster of clients span a wide variety of industries, including information technology, life sciences, energy and clean technology, media and entertainment, communications, retail, and financial services.
Client service is the cornerstone of our practice, and we strive to act as strategic partners to our clients by leveraging our expertise to provide innovative, responsive, and cost-effective legal services. We understand that the law is often a means to accomplish our clients' business objectives, and we pride ourselves on our intimate understanding of their industries and marketplaces. We also know that today's enterprises are facing unprecedented changes in the business, regulatory, and global landscapes, and we have the knowledge and experience to help them confidently adapt to such challenges with state-of-the-art solutions.
Wilson Sonsini Goodrich & Rosati has offices in Austin; Beijing; Boston; Brussels; Hong Kong; Los Angeles; New York; Palo Alto; San Diego; San Francisco; Seattle; Shanghai; Washington, D.C.; and Wilmington, DE.
Our Track Record
Advise more than 300 public enterprises and 3,000 private companies
Consistently named one of "America's Best Corporate Law Firms" by Corporate Board Member
Represent more companies that receive venture financing than any other U.S. law firm and consistently rank No. 1 by Dow Jones VentureSource for the number of venture capital deals handled each year
Completed more than 100 public equity and debt offerings over the past five years, helping clients raise more than approximately $50 billion
Have advised more U.S. companies in their initial public offerings than any other law firm since 1998
Provided representation in more than 500 M&A transactions valued at over $150 billion in the last five years
Annually rank among the top 10 M&A advisors in the U.S. and represent more technology enterprises in mergers and acquisitions than any other U.S. law firm
Consistently acknowledged as one of the nation's leading securities litigation firms
Litigated more than 200 patent lawsuits throughout the U.S. over the past five years and rank among the country's top law firms by number of patent cases defended
Ranked among the top 15 percent of all law firms for both IP litigation and securities and finance litigation based on feedback from corporate counsel at the world's largest companies
Recognized among the top firms in The American Lawyer's annual Diversity Scorecard, based on our high percentages of minority attorneys and partners
Provide more than 35,000 hours of pro bono legal work annually
Global Reach
With long-standing roots in Silicon Valley and 15 offices in technology, business, and regulatory hubs worldwide, Wilson Sonsini Goodrich & Rosati has a national presence with a global reach. Over the past five decades, we have developed a wide-ranging international practice, with particular strength in North America, Asia, and Europe.
Our global experience includes the representation of both U.S. and international clients in such matters as litigation, cross-border mergers and acquisitions, joint ventures, competition law, intellectual property counseling, and branch operations. Our clients span a broad array of industries, from energy to media and Internet, medical devices to food services, pharmaceuticals to many technology sectors. Among numerous other transactions and cases, our attorneys have represented a France-based energy conglomerate in its $1.3 billion acquisition of a solar-panel maker, a leading Taiwanese manufacturer of liquid crystal displays in a patent infringement suit, a major U.S. biotechnology company in its sale to a global pharmaceutical company based in Switzerland, an India-based software services company in a landmark Nasdaq IPO and its $1.6 billion secondary offering of American Depository Shares, and a China-based semiconductor company in its private-placement transactions and its $1.8 billion IPO of American Depository Shares. We also have represented a leading supplier of marine fuel products in its IPO on the Singapore exchange; Japanese companies in a variety of investments, acquisitions, joint ventures, licensing agreements, and formation of subsidiaries; a Taiwanese fabless semiconductor company in a high-profile litigation case before the International Trade Commission (ITC); a leading global medical device company in its nearly $500 million sale of business segments to a Danish life sciences company; and a Chinese medical and health products company in an ITC investigation.
I'd appreciate it if you could delete my last post.
I want the credit!
inWith Corps and H8ster..?? At 0:47 --- wow...: wag the dog !!
EPGL mentioned again as working with Apple...
https://labiotech.eu/contact-lens-glucose-diabetes/
Maybe we will learn more in a few more days...
http://www.otcmarkets.com/financialReportViewer?symbol=EPGL&id=166395
New International Patent Published for EPGL on February 1st, 2017
SYSTEM AND METHOD FOR CONTACT LENS WIRELESS COMMUNICATION
https://patentscope.wipo.int/search/en/detail.jsf?docId=EP191876873&recNum=1&maxRec=256&office=&prevFilter=&sortOption=Pub+Date+Desc&queryString=PA%3A%28markus+david%29+&tab=NationalBiblio
EPGL looking to be the leader in smart lens technology. No other companies appear close to having the technology to make it happen.
I wonder if this could be the patent that Mr Hayes Tweeted about on Friday...
https://www.google.com/patents/WO2016161463A1?cl=en&dq=optic+%26+data+display+within+contact+lens+%2B+David+Markus&hl=en&sa=X&ved=0ahUKEwizgeGfu_fRAhXH2SYKHUioChoQ6AEIGjAA
Great opportunities with EPGL. They are the only company with IP to actually build smart contact lenses and will soon have them in production . Any other companies close? Google, Novartis have both failed.
I was able to Buy 11395 this morning @ .0265. I couldn't get my order filled until I lowered my Bid. Strange Doings
Yes vote for me :)
Let's vote and get this deal done! Time to make the donuts!
$$$$$$$$$$$$$$$$$$$$$ InWith $$$$$$$$$$$$$$$$$$$$$$$$$$$$$
"The offer is 9.8 cents / share OR 125% conversion equivalent. Gifted shares would be on top...."
"EPGL vote to approve + capital raise contingency is included."
Welcome! Lot of good stuff happening with BioMem technology and the current company being discussed. EPGL.
Good to see you all showing up! Let's get the discussion about what this one company, $EPGL, is doing in regards to putting smart technology into our eyes! Very interesting stuff. ;)
Ha, it took a few tries but I made it to ihub, Lol! Hola people!
That's great Viking, look forward seeing it
Hope to work on ibox tomorrow,(worst case this weekend) was going to do it tonight but got sidetracked
wazzz up cheeva
I'm locked out too and trying to remember where I hid that key.
Followers
|
29
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
486
|
Created
|
02/01/17
|
Type
|
Free
|
Moderator H8ster | |||
Assistants vikingzskillz davidr2448 |
Posts Today
|
0
|
Posts (Total)
|
486
|
Posters
|
|
Moderator
|
|
Assistants
|
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |